The role of adriamycin and epirubicin in superficial bladder cancer and carcinoma in situ.
da Silva
F C
FC
Hospital do Desterro, Department of Urology, Lisboa, Portugal.
D002278:Carcinoma in Situ / Q000188:drug therapy*; D002291:Carcinoma, Papillary / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000627:therapeutic use*; D015251:Epirubicin / Q000627:therapeutic use*; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D015251:Epirubicin; D004317:Doxorubicin